🌟 Exciting News! Our US product, Red Yeast Rice, is a finalist for the Nutraingredient USA Awards 2023! 🌟 Did you know that 80% of Americans have low or moderate cardiovascular health, often requiring multiple medications and devices to manage their cholesterol and blood sugar levels? The vicious cycle of cardiovascular health and diabetes is well-known, but dyslipidemia and AGE accumulation accelerate organ inflammation and lead to such deterioration. Moreover, the Western diet, which is full of AGEs, and COVID-19 have aggravated this already grim scenario. At SunWay, we’re both grateful and thrilled that the judges for the NutraIngredients USA Awards have selected our US ANKASCIN 568-R product as a Finalist in the 2023 Botanical category. Let’s root for Red Yeast Rice to win the championship together! Learn more about how #ANKASCIN568 can manage cardiovascular health and blood sugar: https://sunway.cc/tw/ankascin-568-r-when-science-meets-market-trend-meets-government-policy/ #NutraingredientUSA #Finalist #RedYeastRice #CardiovascularHealth #BloodSugarManagement #Innovation   Disclaimer: This communication is only intended for business-to-business. Nothing on this page is meant to be perceived as an approved claim by regulatory authorities.

  “The superior effects of MS and AK in ANKASCIN® 568-R show significant results, from managing glycation and inflammation to improving hyperglycemia, hyperlipidemia, hypertension, and cognitive health. This novel ingredient is clinically proven, safe, has multiple applications in dietary supplements and functional food, is compliant with EU and US regulations, and provides excellent support for healthy aging.”   According to the WHO, around one in ten people in Europe or US has diabetes, which means that if you go out with your relatives, there’s a good chance that the person you’re arm-in-arm with is someone who has diabetes. Chronic diabetic complications, including hyperlipidemia, hypertension, or Alzheimer’s disease, have been related to advanced glycation end product (AGE) accumulation. Glycation and AGEs lead to accelerated organ aging, thus causing the vicious cycle of tissue glycation and aging. However, the Western diet, which is full of AGEs, and COVID-19 have aggravated this already grim scenario. Reports show that patients with hyperglycemia and COVID-19 have a 2-to-4-fold risk of severe COVID-19 or death than those without diabetes. ANKASCIN® 568-R is a state-of-the-art ingredient containing high MS and AK levels. It addresses the root cause, mainly via PPARγ/Nrf2 pathways, to manage anti-glycation, antioxidant, and anti-inflammation and acts synergistically in improving the impairment of pancreatic β-cell function (blood glucose regulation), resolving lipid plaque accumulation in the blood […]

🌟 Exciting News! NIANGJIA Monascus Capsule is the first product of Taiwan recognized as a finalist for the Nutraingredient Asia Awards 2023: Botanical Product of the Year! 🌟 The specialty of #ANKASCIN568R is that it contains high levels of Monascin and Ankaflavin, showing anti-glycation, anti-inflammatory, and antioxidant abilities via #PPAR and #Nrf2 pathways to improve hyperglycemia, preventing fatty plaque accumulation for cardiovascular health, and ameliorating pathogenesis of Alzheimer’s decline to enhance cognitive function, having beneficial effects for healthy aging benefits. We are grateful to our dedicated R&D teams and the unwavering support from our valued customers. Let’s root for NIANGJIA Monascus Capsule to win the championship together! 💪 #NutraingredientAsia #Finalist #antiaging #CardiovascularHealth #BloodSugarManagement #NIUawards23 #RedYeastRice